Document Detail

Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
MedLine Citation:
PMID:  19512943     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We examined whether a specific increase in sympathetic nervous system (SNS) activity accounts for the enhanced depressor response to ganglion blockade in angiotensin II (AngII)-induced hypertension in rabbits or whether it reflects a general increased sensitivity of arterial pressure to vasodilatation. METHODS: Rabbits were renal denervated or sham-operated and 2 weeks later AngII (50 ng/kg per min) infusion commenced. Mean arterial pressure (MAP) responses to ganglion blockade (pentolinium) and vasodilators nitroprusside and adenosine were measured 2-4 weeks later. RESULTS: Basal MAP was 74 +/- 2 mmHg and maximum hypotensive responses to pentolinium, nitroprusside and adenosine were -17 +/- 2, -17 +/- 1 and -21 +/- 2 mmHg. AngII increased MAP similarly in intact and renal denervated rabbits (+25 +/- 4 mmHg and +31 +/- 4 mmHg, respectively). In intact rabbits, depressor responses to pentolinium were augmented by 75% during AngII infusion but responses to vasodilators also increased by 73-106% suggesting general augmentation of vascular reactivity rather than a specific increase in SNS neural activity. Consistent with this notion, total noradrenaline spillover was similar in normal and AngII-treated rabbits. In renal denervated rabbits, AngII enhanced depressor responses to vasodilators but not pentolinium, suggesting that sympathetic activity may be reduced by AngII hypertension when renal nerves are absent. In anaesthetized rabbits, methoxamine-induced decreases in hindlimb vascular conductance were greater in hypertensive than normotensive rabbits suggesting the presence of vascular hypertrophy of sufficient magnitude to explain increased responses to ganglion blockade and vasodilators. CONCLUSION: Enhanced depressor responses to ganglion blockade in AngII hypertension do not reflect augmented SNS activity, but rather, augmented sympathetic vasoconstriction mediated by a vascular amplifier effect.
John-Luis Moretti; Sandra L Burke; Roger G Evans; Gavin W Lambert; Geoffrey A Head
Related Documents :
11353663 - Baroreflex depression persists in the early phase after hypertension reversal.
16616703 - Localized gene transfer and its application for the study of central cardiovascular con...
2869773 - Effect of vecuronium on intraocular pressure.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  27     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-20     Completed Date:  2009-11-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1838-48     Citation Subset:  IM    
Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / pharmacology
Angiotensin II
Blood Pressure
Ganglionic Blockers / pharmacology
Hindlimb / blood supply
Hypertension / blood,  etiology*,  physiopathology
Kidney / innervation
Nitroprusside / pharmacology
Norepinephrine / blood
Pentolinium Tartrate / pharmacology
Regional Blood Flow
Sympathetic Nervous System / physiopathology*
Vascular Resistance
Vasodilator Agents / pharmacology
Reg. No./Substance:
0/Ganglionic Blockers; 0/Vasodilator Agents; 11128-99-7/Angiotensin II; 15078-28-1/Nitroprusside; 51-41-2/Norepinephrine; 52-62-0/Pentolinium Tartrate; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Serum uric acid and prehypertension among Chinese adults.
Next Document:  The relationship between blood pressure and left ventricular mass index depends on an excess adiposi...